Next Generation Sequencing (Ngs) Marktgröße Und Prognose Bis 2031

Global Next Generation Sequencing Ngs Market

Marktgröße in Milliarden USD

CAGR : 15.10 %

USD 13.88 Billion USD 40.78 Billion 2023 2031

Prognosezeitraum	2024 –2031
Marktgröße (Basisjahr)	USD 13.88 Billion
Marktgröße (Prognosejahr)	USD 40.78 Billion
CAGR	15.10 %
Wichtige Marktteilnehmer	Agilent Technologies ThermoFisher Scientific QIAGEN Illumina BioRad Laboratories

Globaler Markt für Next Generation Sequencing (NGS), nach Produkt und Service (Verbrauchsmaterialien, Dienstleistungen und Instrumente), Technologie (Sequenzierung durch Synthese (SBS), Sequenzierung durch Ligation (SBL) und andere), Anwendung (Pharma-Mikrobiologie, Arzneimittel- und Biomarkerforschung, Diagnostik, Präzisionsmedizin, Agrar- und Tierforschung, Screening auf Lebensmittelpathogene und andere), Endbenutzer (Pharma- und Biotechnologieunternehmen, akademische und Forschungsinstitute, Krankenhäuser und Kliniken, klinische Labore, Auftragsforschungsinstitute (CROS) und andere), Vertriebskanal (direkte Ausschreibung, Einzelhandelsverkauf und andere) – Branchentrends und Prognose bis 2031.

Get Exclusive Sample PDF of this Report Here

Marktanalyse und -größe für Next Generation Sequencing (NGS)

Der globale Markt für Next Generation Sequencing (NGS) wird durch die steigende Nachfrage nach personalisierter Medizin und die zunehmende Nutzung von NGS-Technologien in klinischen Diagnostik- und Forschungsanwendungen angetrieben. Ein Hemmnis für das Marktwachstum sind jedoch die mit NGS-Verfahren verbundenen hohen Kosten, die ihre Zugänglichkeit in Entwicklungsregionen einschränken. Eine Chance auf diesem Markt liegt in den Fortschritten bei NGS-Technologien, wie z. B. verbesserten Datenanalysetools und schnelleren Sequenzierungsplattformen, die die Effizienz und Genauigkeit von Sequenzierungsprozessen verbessern können. Eine Herausforderung ist die Notwendigkeit standardisierter Protokolle und Vorschriften für NGS-basierte Tests, um Konsistenz und Zuverlässigkeit in verschiedenen Laboren und Gesundheitseinrichtungen sicherzustellen.

Get Exclusive Sample PDF of this Report Here

Markt für Next Generation Sequencing (NGS)

Get Exclusive Sample PDF of this Report Here

Data Bridge Market Research analysiert, dass der globale Markt für Next Generation Sequencing (NGS) im Prognosezeitraum von 2024 bis 2031 mit einer durchschnittlichen jährlichen Wachstumsrate (CAGR) von 15,1 % wächst und von 13,88 Milliarden US-Dollar im Jahr 2023 auf 40,78 Milliarden US-Dollar im Jahr 2031 ansteigen dürfte.

Berichtsmetrik	Details
Prognosezeitraum	2024 bis 2031
Basisjahr	2023
Historische Jahre	2022 (Anpassbar 2016–2021)
Quantitative Einheiten	Umsatz in Milliarden USD
Abgedeckte Segmente	Produkt und Service (Verbrauchsmaterialien, Services und Instrumente), Technologie (Sequenzierung durch Synthese (SBS), Sequenzierung durch Ligation (SBL) und andere), Anwendung (Pharmazeutika-Mikrobiologie, Arzneimittel- und Biomarkerforschung, Diagnostik, Präzisionsmedizin , Agrar- und Tierforschung, Screening auf Lebensmittelpathogene und andere), Endbenutzer (Pharmazeutika- und Biotechnologieunternehmen, akademische und Forschungsinstitute, Krankenhäuser und Kliniken, klinische Labore, Auftragsforschungsinstitute (CROS) und andere), Vertriebskanal (Direktausschreibung, Einzelhandelsverkauf und andere)
Abgedeckte Länder	USA, Kanada und Mexiko, Großbritannien, Deutschland, Frankreich, Spanien, Italien, Belgien, Russland, Schweiz, Niederlande, Türkei, übriges Europa, China, Australien, Japan, Indien, Singapur, Südkorea, Malaysia, Thailand, Indonesien, Philippinen, übriger Asien-Pazifik-Raum, Brasilien, Argentinien und übriges Südamerika, Südafrika, Ägypten, Saudi-Arabien, Vereinigte Arabische Emirate, Israel und übriger Naher Osten und Afrika
Abgedeckte Marktteilnehmer	Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Merck KGaA, Charles River Laboratories, Revvity, Promega Corporation., Agilent Technologies, Inc., Takara Bio Inc., Eurofins Scientific, Hamilton Company, BGI, Azenta US, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., PacBio., Macrogen, Inc., Gilson Incorporated, New England Biolabs, Oxford Nanopore Technologies plc., LGC Biosearch Technologies, PCR Biosystems, ACT Genomics, Quantabio, DNASTAR und NimaGen. unter anderem

Get Exclusive Sample PDF of this Report Here

Marktdefinition

Next Generation Sequencing (NGS), auch als Hochdurchsatzsequenzierung bezeichnet, ist eine leistungsstarke Technologie zur schnellen Sequenzierung von DNA und RNA. Im Gegensatz zur traditionellen Sanger-Sequenzierung, die langsamer und teurer ist, ermöglicht NGS die gleichzeitige Sequenzierung von Millionen von DNA-Fragmenten, sodass Forscher große Genome schnell und effizient analysieren, genetische Variationen identifizieren und Genexpressionsmuster untersuchen können. NGS hat die Genomforschung revolutioniert und neue Einblicke in die genetische Grundlage von Krankheiten, die Vielfalt mikrobieller Gemeinschaften und die Evolution von Arten ermöglicht.

Globale Marktdynamik für Next Generation Sequencing (NGS)

In diesem Abschnitt geht es um das Verständnis der Markttreiber, Vorteile, Chancen, Einschränkungen und Herausforderungen. All dies wird im Folgenden ausführlich erläutert:

Treiber

Zunahme der Anwendung genomfokussierter Pharmakologie

Die zunehmende Nutzung der Genompharmakologie ist ein wichtiger Treiber für den globalen Markt für Next Generation Sequencing (NGS) und verändert die Landschaft der personalisierten Medizin und gezielten Therapien. Da Gesundheitsdienstleister den Wert maßgeschneiderter Behandlungen auf der Grundlage individueller genetischer Profile erkennen, ist die Nachfrage nach hochdurchsatzfähiger, präziser Genomsequenzierung stark gestiegen. NGS-Technologien ermöglichen eine umfassende Analyse des Genoms eines Patienten und ermöglichen die genaue Identifizierung genetischer Varianten, die die Reaktion auf Medikamente, Resistenzen und potenzielle Nebenwirkungen beeinflussen. Diese personalisierten Erkenntnisse helfen Ärzten bei der Auswahl der wirksamsten und sichersten Behandlungen für jeden Patienten, verbessern die Ergebnisse und reduzieren die Zahl der Verschreibungen nach dem Prinzip „Versuch und Irrtum“. Infolgedessen wächst der NGS-Markt schnell, angetrieben durch die zunehmende Nutzung der Genompharmakologie in verschiedenen medizinischen Bereichen und ihr Potenzial, die Patientenversorgung und -ergebnisse zu revolutionieren.

Breites Produktportfolio der wichtigsten Akteure

Ein breites Produktportfolio der Marktteilnehmer ist ein wichtiger Wachstumstreiber für den globalen Markt für Next Generation Sequencing (NGS), da es den Kunden eine umfassende Auswahl an Lösungen für unterschiedliche Forschungs- und klinische Anforderungen bietet. Durch das Angebot einer Vielzahl von NGS-Plattformen, Verbrauchsmaterialien und Software können die Marktteilnehmer auf unterschiedliche Komplexitätsgrade der Forschung, Durchsatzanforderungen und Budgetbeschränkungen eingehen. Diese Vielseitigkeit ermöglicht es Forschern und Klinikern, die am besten geeigneten Tools für ihre spezifischen Anwendungen auszuwählen, sei es Gesamtgenomsequenzierung, gezielte Sequenzierung oder Transkriptomanalyse. Darüber hinaus kann ein breites Portfolio spezialisierte Angebote wie Kits für die Krebsgenomik, Mikrobiomstudien und die Erforschung seltener Krankheiten umfassen, was für eine breite Palette von Kunden in Wissenschaft, Gesundheitswesen und Industrie noch attraktiver ist.

Get Exclusive Sample PDF of this Report Here

Gelegenheit

Zunehmender Fortschritt in der NGS-Technologie

Verbesserte Sequenzierungsgeschwindigkeit, Genauigkeit, Skalierbarkeit und Kosteneffizienz haben die Anwendungsmöglichkeiten von NGS in verschiedenen Bereichen wie Genomik , Onkologie und Infektionskrankheiten deutlich erweitert . Diese Ausweitung der Anwendungen hat nicht nur die Nachfrage nach NGS-Technologien erhöht, sondern auch neue Märkte erschlossen. Darüber hinaus haben die sinkenden Sequenzierungskosten NGS für Forscher, Kliniker und Patienten zugänglicher gemacht, was seine Akzeptanz in der klinischen Diagnostik und personalisierten Medizin weiter vorantreibt. Darüber hinaus verbessern laufende technologische Innovationen, wie die Entwicklung von Sequenzierungstechnologien für lange Lesevorgänge und tragbaren Sequenzierungsgeräten, die Leistung und Benutzerfreundlichkeit von NGS-Plattformen weiter und steigern ihren Wertbeitrag für Kunden.

Einschränkung/Herausforderung

Komplexität bei der Implementierung von NGS im klinischen Labor

Die Implementierung der Sequenzierung der nächsten Generation (NGS) in klinischen Laboren ist mit mehreren Einschränkungen verbunden, die das Wachstum des NGS-Marktes behindern können. Eine der größten Einschränkungen ist die Komplexität und Variabilität der NGS-Daten. Die enorme Menge der generierten genetischen Daten erfordert anspruchsvolle bioinformatische Tools zur Analyse und Interpretation. Klinische Labore müssen in diese Ressourcen und in qualifiziertes Personal investieren, um genaue und umsetzbare Ergebnisse zu gewährleisten, was ein Hindernis für die Einführung darstellen kann. Eine weitere Einschränkung ist die Nachfrage nach fortschrittlichen Instrumenten und Spezialgeräten für NGS. Diese Instrumente können teuer sein und ihre Wartung erfordert erhebliche Investitionen in Infrastruktur und technisches Know-how. Kleinere klinische Labore haben möglicherweise Schwierigkeiten, die Kosten dieser Investitionen zu rechtfertigen, was die flächendeckende Implementierung von NGS einschränkt.

Jüngste Entwicklungen

Im April 2024 hat Merck KGaA den branchenweit ersten validierten All-in-One-Test zur genetischen Stabilität eingeführt. Der Aptegra CHO-Test zur genetischen Stabilität nutzt die Sequenzierung des gesamten Genoms und Bioinformatik, um die Biosicherheitstests für Kunden zu beschleunigen und ihnen den Übergang zur kommerziellen Produktion zu erleichtern. Diese Innovation wird Merck KGaA dabei helfen, die Biosicherheitstests für Kunden zu rationalisieren, einen schnelleren Übergang zur kommerziellen Produktion zu ermöglichen und ihre Wettbewerbsfähigkeit auf dem Markt zu verbessern
Im Januar 2024 hat QIAGEN seine QIAGEN CLC Genomics Workbench Premium mit LightSpeed-Technologie aufgerüstet, um Unterstützung für Next-Generation-Sequencing (NGS) in der Sekundäranalyse von somatischem Krebs zu bieten. Dieser Softwarebeschleuniger konvertiert Rohsequenzierungsdaten aus FASTQ-Dateien effizient in interpretierbare Listen genetischer Varianten in VCF-Dateien – und das zu bemerkenswert niedrigen Kosten und mit hoher Geschwindigkeit. Dieses Upgrade stärkt das Angebot von QIAGEN und bietet Kunden eine schnellere, kostengünstigere Lösung für die NGS-Analyse von somatischem Krebs und steigert so ihre Wettbewerbsfähigkeit.
Im Januar 2024 ist Beckman Coulter, Inc. eine Partnerschaft mit Polycarbin eingegangen, einem Vorreiter im Bereich nachhaltiger Laborlösungen. Gemeinsam wollen sie die Nachhaltigkeit von Laboren für die Automatisierung der Flüssigkeitshandhabung mit Kunststoffen revolutionieren. Diese Zusammenarbeit vereint die Expertise von Beckman Coulter Life Sciences im Bereich der automatisierten Flüssigkeitshandhabung mit der Kreislaufwirtschaftsplattform von Polycarbin und konzentriert sich auf die Nachhaltigkeit von Laborkunststoffen.
Im November 2023 haben QIAGEN und DNA Labs International zusammengearbeitet, um zwei Jahrzehnte alte ungeklärte Fälle aufzuklären. Dabei kamen QIAGENs ForenSeq Kintelligence System für forensische genetische Genealogie in Verbindung mit der GEDmatch PRO-Datenbank zum Einsatz. Dies unterstreicht die Wirksamkeit und zunehmende Akzeptanz dieses Ansatzes zur Identifizierung von Menschen. Dies wird die Wirksamkeit der Lösungen von QIAGEN zur forensischen genetischen Genealogie steigern und ihre Akzeptanz und ihren Umsatz auf dem forensischen Markt potenziell steigern.
Im November 2023 hat Beckman Coulter, Inc. eine Kooperationsvereinbarung mit Pillar Biosciences geschlossen, einem Entwickler und Vertreiber von IVD- und RUO-NGS-Testlösungen unter Verwendung der proprietären SLIMamp-Technologie. Im Rahmen der Vereinbarung wird Pillar Biosciences eine Reihe von Anwendungen für den Einsatz auf dem Biomek NGeniuS Next Generation Library Preparation System erstellen. Diese Zusammenarbeit wird das Angebot von Beckman Coulter durch die Integration der fortschrittlichen NGS-Testlösungen von Pillar Biosciences erweitern und Krebspatienten durch eine verbesserte, präzise Therapieauswahl zugutekommen.
Im November 2023 haben QIAGEN und Element Biosciences, Inc. eine strategische Partnerschaft angekündigt, um umfassende Next-Generation-Sequencing-Workflows (NGS) für das Element AVITI System, eine innovative Sequenzierungsplattform, bereitzustellen. Diese Partnerschaft wird QIAGENs Portfolio an NGS-Workflows erweitern und seine Position auf dem Genomikmarkt stärken
Im Oktober 2023 haben Beckman Coulter, Inc. und 10x Genomics eine Partnerschaft geschlossen, um Automatisierungslösungen für Einzelzell-Assay-Workflows zu verbessern. Im Rahmen dieser Zusammenarbeit wird 10x Genomics Chromium Single Cell Kits entwickeln, die auf den Einsatz mit dem Biomek i7 Automated Liquid Handler von Beckman Coulter Life Sciences zugeschnitten sind. Diese maßgeschneiderte Anwendung zielt darauf ab, die Einzelzellbibliotheksvorbereitung von 10x Genomics zu automatisieren und eine qualitativ hochwertige, groß angelegte Produktion fertiger Bibliotheken sicherzustellen, die zur Sequenzierung bereit sind. Diese Partnerschaft wird es Beckman Coulter ermöglichen, verbesserte Automatisierungslösungen für Einzelzell-Assays anzubieten und den Kunden optimierte Arbeitsabläufe und verbesserte Effizienz zu bieten.
Im Oktober 2023 gab Azenta US, Inc. bekannt, dass GENEWIZ Multiomics and Synthesis Solutions von Azenta Life Sciences vom 6. bis 10. November 2023 die GENEWIZ Week ausrichten wird. Die Veranstaltung umfasst virtuelle Workshops, Werbeaktionen und ein Stipendienprogramm für Spitzenforschung in der Genomforschung. Die Ausrichtung der GENEWIZ Week steigerte die Markensichtbarkeit von Azenta, zog neue Kunden an und förderte die Zusammenarbeit in der Genomforschungsgemeinschaft, was letztlich Wachstum und Innovation vorantreibt.
Im September 2023 gaben Charles River Laboratories und PathoQuest SAS, ein Anbieter von Next-Generation-Sequencing-Tests (NGS) für Biopharmazeutika, bekannt, dass sie gemeinsam bahnbrechende Forschungsergebnisse in Vaccine veröffentlicht haben. Diese Studie hob die überlegenen Fähigkeiten von PathoQuests proprietärem, auf NGS basierendem Test in GMP-Qualität (Good Manufacturing Practice) zur Erkennung viraler Verunreinigungen im Vergleich zu In-vivo-Tests hervor. Diese Leistung wird den Ruf des Unternehmens stärken und es als führendes Unternehmen im Bereich biopharmazeutischer Tests positionieren und potenziell mehr Kunden anziehen, die nach fortschrittlichen und zuverlässigen Testlösungen suchen.
Im Mai 2023 hat Charles River Laboratories Accugenix Next Generation Sequencing for Bacterial Identification and Fungal Identification (Accugenix NGS) eingeführt. Diese Technologie sequenziert Millionen einzelner DNA-Fragmente aus einer Probe und bietet Pharma- und Körperpflegeherstellern wichtige Informationen zur mikrobiellen Kontrolle. Die neue Technologie erweitert die Dienstleistungen des Unternehmens und bietet Pharma- und Körperpflegeherstellern fortschrittliche Lösungen zur mikrobiellen Kontrolle, die die Produktqualität und die Einhaltung gesetzlicher Vorschriften verbessern

Globaler Marktumfang für Next Generation Sequencing (NGS)

Der globale Markt für Next Generation Sequencing (NGS) ist in fünf wichtige Segmente unterteilt, basierend auf Produkt und Service, Technologie, Anwendung, Endbenutzer und Vertriebskanal. Das Wachstum zwischen den Segmenten hilft Ihnen dabei, Nischenwachstumsbereiche und Strategien zur Marktbearbeitung zu analysieren und Ihre wichtigsten Anwendungsbereiche und die Unterschiede in Ihren Zielmärkten zu bestimmen.

Produkt und Service

Verbrauchsmaterial
Dienstleistungen
Instrumente

Auf der Grundlage von Produkt und Service ist der globale Markt für Next Generation Sequencing (NGS) in Verbrauchsmaterialien, Dienstleistungen und Instrumente segmentiert.

Technologie

Sequenzierung durch Synthese (SBS)
Sequenzierung durch Ligation (SBL)
Sonstiges

Auf der Grundlage der Technologie ist der globale Markt für Next-Generation-Sequencing (NGS) in Sequenzierung durch Synthese (SBS), Sequenzierung durch Ligation (SBL) und andere unterteilt.

Anwendung

Pharma Mikrobiologie
Arzneimittel- und Biomarkerforschung
Diagnose
Präzisionsmedizin
Agrar- und Tierforschung
Screening auf Lebensmittelpathogene
Sonstiges

Auf der Grundlage der Anwendung ist der globale Markt für Next-Generation-Sequencing (NGS) in die Bereiche Pharmazeutische Mikrobiologie, Arzneimittel- und Biomarkerforschung, Diagnostik, Präzisionsmedizin, Agrar- und Tierforschung, Screening auf Lebensmittelpathogene und andere unterteilt.

Endbenutzer

Pharma- und Biotechnologieunternehmen
Akademische und Forschungsinstitute
Krankenhäuser und Kliniken
Klinische Labore
Vertragsforschungsinstitute (CROS)
Sonstiges

Auf der Grundlage des Endbenutzers ist der globale Markt für Next-Generation-Sequencing (NGS) in Pharma- und Biotechnologieunternehmen, Hochschul- und Forschungsinstitute, Krankenhäuser und Kliniken, klinische Labore, Auftragsforschungsinstitute (CROS) und andere segmentiert.

Vertriebskanal

Direkte Ausschreibung
Einzelhandelsumsätze
Sonstiges

Auf der Grundlage der Vertriebskanäle ist der globale Markt für Next Generation Sequencing (NGS) in Direktausschreibungen, Einzelhandelsverkäufe und Sonstiges unterteilt.

Get Exclusive Sample PDF of this Report Here

Globaler Next Generation Sequencing (NGS)-Markt – Regionale Analyse/Einblicke

Der globale Markt für Next-Generation-Sequencing (NGS) wird analysiert und es werden Erkenntnisse und Trends zur Marktgröße basierend auf Produkt und Service, Technologie, Anwendung, Endbenutzer und Vertriebskanal wie oben angegeben bereitgestellt.

Die in diesem globalen Marktbericht zum Next-Generation-Sequencing (NGS) abgedeckten Länder sind die USA, Kanada und Mexiko, Großbritannien, Deutschland, Frankreich, Spanien, Italien, Belgien, Russland, die Schweiz, die Niederlande, die Türkei, das übrige Europa, China, Australien, Japan, Indien, Singapur, Südkorea, Malaysia, Thailand, Indonesien, die Philippinen, der restliche asiatisch-pazifische Raum, Brasilien, Argentinien und der Rest von Südamerika, Südafrika, Ägypten, Saudi-Arabien, die Vereinigten Arabischen Emirate, Israel sowie der Rest des Nahen Ostens und Afrikas.

Nordamerika wird voraussichtlich den globalen Markt für Next-Generation-Sequencing (NGS) dominieren. Grund dafür sind unter anderem die große Zahl wichtiger Marktteilnehmer, die hohe Akzeptanz von NGS-Technologien in der Forschung und bei klinischen Anwendungen sowie günstige staatliche Initiativen und Fördermittel zur Unterstützung der Genomforschung.

Die USA werden voraussichtlich den nordamerikanischen Markt für Next-Generation-Sequencing (NGS) dominieren. Grund dafür sind unter anderem die Präsenz einer großen Zahl von NGS-Technologieanbietern, erhebliche Investitionen in die Genomforschung und ein unterstützendes regulatorisches Umfeld, das die Einführung von NGS im Klinik- und Forschungsumfeld fördert.

Aufgrund seiner fortschrittlichen Gesundheitsinfrastruktur, der starken staatlichen Unterstützung der Genomforschung und eines gut etablierten Marktes für NGS-Technologien und -Dienste wird Großbritannien voraussichtlich den europäischen Markt für Next-Generation-Sequencing (NGS) dominieren.

Aufgrund der hohen Bevölkerungszahl, der zunehmenden Verbreitung der Präzisionsmedizin, staatlicher Initiativen zur Förderung der Genomforschung und einer wachsenden Zahl von NGS-Technologieanbietern in der Region wird China voraussichtlich den Markt für Next-Generation-Sequencing (NGS) im asiatisch-pazifischen Raum dominieren.

Der Länderabschnitt des Berichts enthält auch individuelle marktbeeinflussende Faktoren und Änderungen der Marktregulierung, die die aktuellen und zukünftigen Trends des Marktes beeinflussen. Datenpunkte wie Downstream- und Upstream-Wertschöpfungskettenanalyse, technische Trends und Porters Fünf-Kräfte-Analyse sowie Fallstudien sind einige der Anhaltspunkte, die zur Prognose des Marktszenarios für einzelne Länder verwendet werden. Auch die Präsenz und Verfügbarkeit globaler Marken und ihre Herausforderungen aufgrund großer oder geringer Konkurrenz durch lokale und inländische Marken sowie die Auswirkungen inländischer Zölle und Handelsrouten werden bei der Bereitstellung einer Prognoseanalyse der Länderdaten berücksichtigt.

Get Exclusive Sample PDF of this Report Here

Wettbewerbsumfeld und globale Marktanteilsanalyse für Next Generation Sequencing (NGS)

Die Wettbewerbslandschaft des globalen Marktes für Next Generation Sequencing (NGS) bietet Details nach Wettbewerbern. Die enthaltenen Details sind Unternehmensübersicht, Unternehmensfinanzen, erzielter Umsatz, Marktpotenzial, Investitionen in Forschung und Entwicklung, neue Marktinitiativen, globale Präsenz, Produktionsstandorte und -anlagen, Produktionskapazitäten, Stärken und Schwächen des Unternehmens, Produkteinführung, Produktbreite und -umfang sowie Anwendungsdominanz. Die oben angegebenen Datenpunkte beziehen sich nur auf den Fokus der Unternehmen auf den globalen Markt für Next Generation Sequencing (NGS).

Zu den wichtigsten Akteuren auf dem globalen Markt für Next-Generation-Sequencing (NGS) zählen unter anderem Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Merck KGaA, Charles River Laboratories, Revvity, Promega Corporation., Agilent Technologies, Inc., Takara Bio Inc., Eurofins Scientific, Hamilton Company, BGI, Azenta US, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., PacBio., Macrogen, Inc., Gilson Incorporated, New England Biolabs, Oxford Nanopore Technologies plc., LGC Biosearch Technologies, PCR Biosystems, ACT Genomics, Quantabio, DNASTAR und NimaGen.

SKU-1736

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

Klicken Sie auf das Bild, um es zu vergrößern

Interaktives Datenanalyse-Dashboard
Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
Zugriff für Research-Analysten für Anpassungen und Abfragen
Konkurrenzanalyse mit interaktivem Dashboard
Aktuelle Nachrichten, Updates und Trendanalyse
Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung

Demo anfordern

Inhaltsverzeichnis

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET APPLICATION COVERAGE GRID

2.8 PRODUCT LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTERS FIVE FORCES

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 INCREASE IN THE ADOPTION OF GENOME-FOCUSED PHARMACOLOGY

5.1.2 WIDE PRODUCT PORTFOLIO OFFERED BY MAJOR PLAYERS

5.1.3 USE OF NEXT GENERATION SEQUENCING IN DRUG DEVELOPMENT

5.1.4 INCREASE TREND TOWARDS PERSONALIZED MEDICATION

5.2 RESTRAINTS

5.2.1 HIGH COST OF INSTALLATION AND MAINTENANCE OF EQUIPMENT’S IN THE LABORATORY

5.2.2 COMPLEXITY DURING IMPLEMENTATION OF NGS IN THE CLINICAL LAB

5.3 OPPORTUNITIES

5.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYERS

5.3.2 INCREASING ADVANCEMENT IN NGS TECHNOLOGY

5.3.3 INCREASING APPLICATIONS OF NGS IN CLINICAL DIAGNOSTICS

5.4 CHALLENGES

5.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM NGS

5.4.2 DATA PRIVACY AND SECURITY

6 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT AND SERVICE

6.1 OVERVIEW

6.2 CONSUMABLES

6.2.1 LIBRARY PREPARATION CONSUMABLES

6.2.2 SAMPLE PREPARATION CONSUMABLES

6.3 SERVICES

6.3.1 SEQUENCING SERVICES

6.3.1.1 RNA SEQUENCING

6.3.1.2 DNA SEQUENCING

6.3.1.2.1 WHOLE GENOME SEQUENCING

6.3.1.2.2 WHOLE EXOME SEQUENCING

6.3.1.2.3 TARGETED SEQUENCING

6.3.1.2.4 CHIP SEQUENCING

6.3.1.2.5 DE NOVO SEQUENCING

6.3.1.2.6 OTHERS

6.3.2 DATA MANAGEMENT SERVICES

6.3.2.1 NGS STORAGE, MANAGEMENT AND CLOUD COMPUTING SOLUTIONS

6.3.2.2 NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES

6.3.2.3 NGS DATA ANALYSIS SERVICES

6.4 INSTRUMENTS

6.4.1 BENCHTOP

6.4.2 STANDALONE

6.4.2.1 AUTOMATED

6.4.2.2 SEMI-AUTOMATED

6.4.2.3 MANUAL

6.4.2.3.1 WORKSTATION/PLATFORM

6.4.2.3.2 SYSTEM

7 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY

7.1 OVERVIEW

7.2 SEQUENCING BY SYNTHESIS (SBS)

7.2.1 PYROSEQUENCING

7.2.2 ION SEMI CONDUCTOR SEQUENCING

7.2.3 NANOPORE SEQUENCING

7.2.4 SINGLE-MOLECULE-REAL-TIME SEQUENCING (SMRT)

7.3 SEQUENCING BY LIGATION (SBL)

7.4 OTHERS

8 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 PHARMACEUTICALS MICROBIOLOGY

8.2.1 MICROBIAL IDENTIFICATION/DETECTION

8.2.2 TARGETED SEQUENCING

8.2.3 CELL LINE CHARACTERIZATION

8.2.4 ANTIMICROBIAL RESISTANCE AND PREDICTING ANTIMICROBIAL SUSCEPTIBILITIES

8.2.5 STRAIN SUBTYPING

8.2.6 OTHERS

8.2.6.1 SEQUENCING BY SYNTHESIS (SBS)

8.2.6.2 SEQUENCING BY LIGATION (SBL)

8.2.6.3 OTHERS

8.3 DRUG & BIOMARKER DISCOVERY

8.3.1 SEQUENCING BY SYNTHESIS (SBS)

8.3.2 SEQUENCING BY LIGATION (SBL)

8.3.3 OTHERS

8.4 DIAGNOSTICS

8.4.1 CANCER DIAGNOSTICS

8.4.2 INFECTIOUS DISEASE DIAGNOSTICS

8.4.3 REPRODUCTIVE HEALTH DIAGNOSTICS

8.4.4 OTHER DIAGNOSTIC APPLICATIONS

8.4.4.1 SEQUENCING BY SYNTHESIS (SBS)

8.4.4.2 SEQUENCING BY LIGATION (SBL)

8.4.5 OTHERS

8.5 PRECISION MEDICINE

8.5.1 SEQUENCING BY SYNTHESIS (SBS)

8.5.2 SEQUENCING BY LIGATION (SBL)

8.5.3 OTHERS

8.6 AGRICULTURAL & ANIMAL RESEARCH

8.6.1 SEQUENCING BY SYNTHESIS (SBS)

8.6.2 SEQUENCING BY LIGATION (SBL)

8.6.3 OTHERS

8.7 FOOD PATHOGEN SCREENING

8.8 OTHERS

9 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER

9.1 OVERVIEW

9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

9.3 ACADEMIC & RESEARCH INSTITUTES

9.4 HOSPITALS & CLINICS

9.5 CLINICAL LABORATORIES

9.6 CONTRACT RESEARCH ORGANIZATIONS (CROS)

9.7 OTHERS

10 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW

10.2 DIRECT TENDER

10.3 RETAIL SALES

10.3.1 OFFLINE

10.3.2 ONLINE

10.4 OTHERS

11 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION

11.1 OVERVIEW

11.2 NORTH AMERICA

11.2.1 U.S.

11.2.2 CANADA

11.2.3 MEXICO

11.3 EUROPE

11.3.1 U.K.

11.3.2 GERMANY

11.3.3 FRANCE

11.3.4 SPAIN

11.3.5 ITALY

11.3.6 BELGIUM

11.3.7 RUSSIA

11.3.8 SWITZERLAND

11.3.9 NETHERLANDS

11.3.10 TURKEY

11.3.11 REST OF EUROPE

11.4 ASIA-PACIFIC

11.4.1 CHINA

11.4.2 AUSTRALIA

11.4.3 JAPAN

11.4.4 INDIA

11.4.5 SINGAPORE

11.4.6 SOUTH KOREA

11.4.7 MALAYSIA

11.4.8 THAILAND

11.4.9 INDONESIA

11.4.10 PHILIPPINES

11.4.11 REST OF ASIA-PACIFIC

11.5 SOUTH AMERICA

11.5.1 BRAZIL

11.5.2 ARGENTINA

11.5.3 REST OF SOUTH AMERICA

11.6 MIDDLE EAST AND AFRICA

11.6.1 SOUTH AFRICA

11.6.2 SAUDI ARABIA

11.6.3 U.A.E.

11.6.4 ISRAEL

11.6.5 REST OF MIDDLE EAST AND AFRICA

12 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: GLOBAL

12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

12.3 COMPANY SHARE ANALYSIS: EUROPE

12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

13 SWOT ANALYSIS

14 COMPANY PROFILING

14.1 ILLUMINA, INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUEANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENTS

14.2 THERMO FISHER SCIENTIFIC INC.

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENTS

14.3 QIAGEN

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENTS

14.4 MERCK KGAA

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENT

14.5 CHARLES RIVER LABORATORIES

14.5.1 COMPANY SNAPSHOT

14.5.2 REVENUE ANALYSIS

14.5.3 COMPANY SHARE ANALYSIS

14.5.4 PRODUCT PORTFOLIO

14.5.5 RECENT DEVELOPMENTS

14.6 ACT GENOMICS

14.6.1 COMPANY SNAPSHOT

14.6.2 PRODUCT PORTFOLIO

14.6.3 RECENT DEVELOPMENTS

14.7 AGILENT TECHNOLOGIES, INC.

14.7.1 COMPANY SNAPSHOT

14.7.2 REVENUE ANALYSIS

14.7.3 PRODUCT PORTFOLIO

14.7.4 RECENT DEVELOPMENT

14.8 AZENTA US, INC.

14.8.1 COMPANY SNAPSHOT

14.8.2 REVENUE ANALYSIS

14.8.3 PRODUCT PORTFOLIO

14.8.4 RECENT DEVELOPMENT

14.9 BECKMAN COULTER, INC.

14.9.1 COMPANY SNAPSHOT

14.9.2 PRODUCT PORTFOLIO

14.9.3 RECENT DEVELOPMENTS

14.1 BIO-RAD LABORATORIES, INC.

14.10.1 COMPANY SNAPSHOT

14.10.2 REVENUE ANALYSIS

14.10.3 PRODUCT PORTFOLIO

14.10.4 RECENT DEVELOPMENTS

14.11 BGI (A SUBSIDIAIRY OF BGI GROUP) (2024)

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENT

14.12 DNASTAR

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENT

14.13 EUROFINS SCIENTIFIC

14.13.1 COMPANY SNAPSHOT

14.13.2 REVENUE ANALYSIS

14.13.3 PRODUCT PORTFOLIO

14.13.4 RECENT DEVELOPMENTS

14.14 GILSON INCORPORATED

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENT

14.15 HAMILTON COMPANY

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT DEVELOPMENT

14.16 LGC BIOSEARCH TECHNOLOGIES

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT DEVELOPMENTS

14.17 MACROGEN, INC.

14.17.1 COMPANY SNAPSHOT

14.17.2 REVENUE ANALYSIS

14.17.3 PRODUCT PORTFOLIO

14.17.4 RECENT DEVELOPMENT

14.18 NEW ENGLAND BIOLABS

14.18.1 COMPANY SNAPSHOT

14.18.2 PRODUCT PORTFOLIO

14.18.3 RECENT DEVELOPMENT

14.19 NIMAGEN

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENT

14.2 OXFORD NANOPORE TECHNOLOGIES PLC.

14.20.1 COMPANY SNAPSHOT

14.20.2 REVENUE ANALYSIS

14.20.3 PRODUCT PORTFOLIO

14.20.4 RECENT DEVELOPMENTS

14.21 PACBIO.

14.21.1 COMPANY SNAPSHOT

14.21.2 REVENUE ANALYSIS

14.21.3 PRODUCT PORTFOLIO

14.21.4 RECENT DEVELOPMENTS

14.22 PCR BIOSYSTEMS

14.22.1 COMPANY SNAPSHOT

14.22.2 PRODUCT PORTFOLIO

14.22.3 RECENT DEVELOPMENTS

14.23 PROMEGA CORPORATION.

14.23.1 COMPANY SNAPSHOT

14.23.2 PRODUCT PORTFOLIO

14.23.3 RECENT DEVELOPMENTS

14.24 QUANTABIO

14.24.1 COMPANY SNAPSHOT

14.24.2 PRODUCT PORTFOLIO

14.24.3 RECENT DEVELOPMENT

14.25 REVVITY

14.25.1 COMPANY SNAPSHOT

14.25.2 REVENUE ANALYSIS

14.25.3 PRODUCT PORTFOLIO

14.25.4 RECENT DEVELOPMENT

14.26 TAKARA BIO INC.

14.26.1 COMPANY SNAPSHOT

14.26.2 REVENUE ANALYSIS

14.26.3 PRODUCT PORTFOLIO

14.26.4 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

Tabellenverzeichnis

TABLE 1 INSTRUMENT COST PER RUN

TABLE 2 PLATFORM /COMPANY COST PER RUN

TABLE 3 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 4 GLOBAL CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 5 GLOBAL CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 6 GLOBAL SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 7 GLOBAL SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 8 GLOBAL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 9 GLOBAL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 10 GLOBAL DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 11 GLOBAL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 12 GLOBAL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 13 GLOBAL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 14 GLOBAL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 15 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 16 GLOBAL CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 17 GLOBAL SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 18 GLOBAL SEQUENCING BY LIGATION (SBL) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 19 GLOBAL OTHERS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 20 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 21 GLOBAL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 22 GLOBAL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 23 GLOBAL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 24 GLOBAL DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 25 GLOBAL DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 26 GLOBAL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 27 GLOBAL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 28 GLOBAL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 29 GLOBAL PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 30 GLOBAL PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 31 GLOBAL AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 32 GLOBAL AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 33 GLOBAL FOOD PATHOGEN SCREENING IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 34 GLOBAL OTHERS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 35 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 36 GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 37 GLOBAL ACADEMIC & RESEARCH INSTITUTES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 38 GLOBAL HOSPITALS & CLINICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 39 GLOBAL CLINICAL LABORATORIES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 40 GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 41 GLOBAL OTHERS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 42 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 43 GLOBAL DIRECT TENDER IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 44 GLOBAL RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 45 GLOBAL RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 46 GLOBAL OTHERS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 47 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 48 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 49 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 50 NORTH AMERICA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 51 NORTH AMERICA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 52 NORTH AMERICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 53 NORTH AMERICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 54 NORTH AMERICA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 55 NORTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 56 NORTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 57 NORTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 58 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 59 NORTH AMERICA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 60 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 61 NORTH AMERICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 62 NORTH AMERICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 63 NORTH AMERICA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 64 NORTH AMERICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 65 NORTH AMERICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 66 NORTH AMERICA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 67 NORTH AMERICA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 68 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 69 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 70 NORTH AMERICA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 71 U.S. NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 72 U.S. CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 73 U.S. SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 74 U.S. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 75 U.S. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 76 U.S. DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 77 U.S. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 78 U.S. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 79 U.S. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 80 U.S. NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 81 U.S. SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 82 U.S. NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 83 U.S. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 84 U.S. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 85 U.S. DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 86 U.S. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 87 U.S. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 88 U.S. PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 89 U.S. AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 90 U.S. NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 91 U.S. NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 92 U.S. RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 93 CANADA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 94 CANADA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 95 CANADA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 96 CANADA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 97 CANADA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 98 CANADA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 99 CANADA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 100 CANADA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 101 CANADA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 102 CANADA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 103 CANADA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 104 CANADA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 105 CANADA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 106 CANADA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 107 CANADA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 108 CANADA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 109 CANADA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 110 CANADA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 111 CANADA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 112 CANADA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 113 CANADA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 114 CANADA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 115 MEXICO NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 116 MEXICO CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 117 MEXICO SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 118 MEXICO SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 119 MEXICO SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 120 MEXICO DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 121 MEXICO INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 122 MEXICO INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 123 MEXICO INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 124 MEXICO NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 125 MEXICO SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 126 MEXICO NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 127 MEXICO PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 128 MEXICO PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 129 MEXICO DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 130 MEXICO DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 131 MEXICO DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 132 MEXICO PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 133 MEXICO AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 134 MEXICO NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 135 MEXICO NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 136 MEXICO RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 137 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 138 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 139 EUROPE CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 140 EUROPE SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 141 EUROPE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 142 EUROPE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 143 EUROPE DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 144 EUROPE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 145 EUROPE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 146 EUROPE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 147 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 148 EUROPE SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 149 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 150 EUROPE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 151 EUROPE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 152 EUROPE DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 153 EUROPE DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 154 EUROPE DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 155 EUROPE PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 156 EUROPE AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 157 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 158 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 159 EUROPE RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 160 U.K. NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 161 U.K. CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 162 U.K. SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 163 U.K. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 164 U.K. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 165 U.K. DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 166 U.K. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 167 U.K. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 168 U.K. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 169 U.K. NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 170 U.K. SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 171 U.K. NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 172 U.K. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 173 U.K. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 174 U.K. DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 175 U.K. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 176 U.K. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 177 U.K. PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 178 U.K. AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 179 U.K. NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 180 U.K. NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 181 U.K. RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 182 GERMANY NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 183 GERMANY CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 184 GERMANY SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 185 GERMANY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 186 GERMANY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 187 GERMANY DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 188 GERMANY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 189 GERMANY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 190 GERMANY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 191 GERMANY NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 192 GERMANY SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 193 GERMANY NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 194 GERMANY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 195 GERMANY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 196 GERMANY DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 197 GERMANY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 198 GERMANY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 199 GERMANY PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 200 GERMANY AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 201 GERMANY NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 202 GERMANY NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 203 GERMANY RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 204 FRANCE NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 205 FRANCE CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 206 FRANCE SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 207 FRANCE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 208 FRANCE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 209 FRANCE DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 210 FRANCE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 211 FRANCE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 212 FRANCE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 213 FRANCE NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 214 FRANCE SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 215 FRANCE NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 216 FRANCE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 217 FRANCE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 218 FRANCE DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 219 FRANCE DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 220 FRANCE PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 221 FRANCE AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 222 FRANCE NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 223 FRANCE NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 224 FRANCE RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 225 SPAIN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 226 SPAIN CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 227 SPAIN SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 228 SPAIN SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 229 SPAIN SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 230 SPAIN DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 231 SPAIN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 232 SPAIN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 233 SPAIN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 234 SPAIN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 235 SPAIN SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 236 SPAIN NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 237 SPAIN PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 238 SPAIN PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 239 SPAIN DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 240 SPAIN DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 241 SPAIN DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 242 SPAIN PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 243 SPAIN AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 244 SPAIN NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 245 SPAIN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 246 SPAIN RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 247 ITALY NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 248 ITALY CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 249 ITALY SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 250 ITALY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 251 ITALY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 252 ITALY DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 253 ITALY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 254 ITALY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 255 ITALY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 256 ITALY NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 257 ITALY SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 258 ITALY NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 259 ITALY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 260 ITALY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 261 ITALY DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 262 ITALY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 263 ITALY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 264 ITALY PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 265 ITALY AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 266 ITALY NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 267 ITALY NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 268 ITALY RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 269 BELGIUM NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 270 BELGIUM CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 271 BELGIUM SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 272 BELGIUM SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 273 BELGIUM SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 274 BELGIUM DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 275 BELGIUM INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 276 BELGIUM INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 277 BELGIUM INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 278 BELGIUM NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 279 BELGIUM SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 280 BELGIUM NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 281 BELGIUM PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 282 BELGIUM PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 283 BELGIUM DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 284 BELGIUM DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 285 BELGIUM DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 286 BELGIUM PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 287 BELGIUM AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 288 BELGIUM NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 289 BELGIUM NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 290 BELGIUM RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 291 RUSSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 292 RUSSIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 293 RUSSIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 294 RUSSIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 295 RUSSIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 296 RUSSIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 297 RUSSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 298 RUSSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 299 RUSSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 300 RUSSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 301 RUSSIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 302 RUSSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 303 RUSSIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 304 RUSSIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 305 RUSSIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 306 RUSSIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 307 RUSSIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 308 RUSSIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 309 RUSSIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 310 RUSSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 311 RUSSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 312 RUSSIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 313 SWITZERLAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 314 SWITZERLAND CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 315 SWITZERLAND SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 316 SWITZERLAND SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 317 SWITZERLAND SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 318 SWITZERLAND DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 319 SWITZERLAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 320 SWITZERLAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 321 SWITZERLAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 322 SWITZERLAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 323 SWITZERLAND SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 324 SWITZERLAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 325 SWITZERLAND PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 326 SWITZERLAND PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 327 SWITZERLAND DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 328 SWITZERLAND DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 329 SWITZERLAND DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 330 SWITZERLAND PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 331 SWITZERLAND AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 332 SWITZERLAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 333 SWITZERLAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 334 SWITZERLAND RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 335 NETHERLANDS NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 336 NETHERLANDS CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 337 NETHERLANDS SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 338 NETHERLANDS SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 339 NETHERLANDS SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 340 NETHERLANDS DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 341 NETHERLANDS INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 342 NETHERLANDS INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 343 NETHERLANDS INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 344 NETHERLANDS NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 345 NETHERLANDS SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 346 NETHERLANDS NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 347 NETHERLANDS PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 348 NETHERLANDS PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 349 NETHERLANDS DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 350 NETHERLANDS DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 351 NETHERLANDS DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 352 NETHERLANDS PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 353 NETHERLANDS AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 354 NETHERLANDS NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 355 NETHERLANDS NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 356 NETHERLANDS RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 357 TURKEY NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 358 TURKEY CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 359 TURKEY SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 360 TURKEY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 361 TURKEY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 362 TURKEY DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 363 TURKEY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 364 TURKEY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 365 TURKEY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 366 TURKEY NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 367 TURKEY SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 368 TURKEY NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 369 TURKEY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 370 TURKEY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 371 TURKEY DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 372 TURKEY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 373 TURKEY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 374 TURKEY PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 375 TURKEY AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 376 TURKEY NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 377 TURKEY NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 378 TURKEY RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 379 REST OF EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 380 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 381 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 382 ASIA-PACIFIC CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 383 ASIA-PACIFIC SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 384 ASIA-PACIFIC SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 385 ASIA-PACIFIC SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 386 ASIA-PACIFIC DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 387 ASIA-PACIFIC INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 388 ASIA-PACIFIC INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 389 ASIA-PACIFIC INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 390 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 391 ASIA-PACIFIC SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 392 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 393 ASIA-PACIFIC PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 394 ASIA-PACIFIC PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 395 ASIA-PACIFIC DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 396 ASIA-PACIFIC DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 397 ASIA-PACIFIC DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 398 ASIA-PACIFIC PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 399 ASIA-PACIFIC AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 400 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 401 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 402 ASIA-PACIFIC RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 403 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 404 CHINA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 405 CHINA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 406 CHINA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 407 CHINA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 408 CHINA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 409 CHINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 410 CHINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 411 CHINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 412 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 413 CHINA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 414 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 415 CHINA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 416 CHINA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 417 CHINA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 418 CHINA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 419 CHINA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 420 CHINA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 421 CHINA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 422 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 423 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 424 CHINA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 425 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 426 AUSTRALIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 427 AUSTRALIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 428 AUSTRALIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 429 AUSTRALIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 430 AUSTRALIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 431 AUSTRALIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 432 AUSTRALIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 433 AUSTRALIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 434 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 435 AUSTRALIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 436 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 437 AUSTRALIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 438 AUSTRALIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 439 AUSTRALIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 440 AUSTRALIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 441 AUSTRALIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 442 AUSTRALIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 443 AUSTRALIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 444 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 445 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 446 AUSTRALIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 447 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 448 JAPAN CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 449 JAPAN SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 450 JAPAN SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 451 JAPAN SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 452 JAPAN DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 453 JAPAN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 454 JAPAN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 455 JAPAN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 456 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 457 JAPAN SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 458 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 459 JAPAN PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 460 JAPAN PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 461 JAPAN DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 462 JAPAN DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 463 JAPAN DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 464 JAPAN PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 465 JAPAN AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 466 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 467 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 468 JAPAN RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 469 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 470 INDIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 471 INDIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 472 INDIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 473 INDIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 474 INDIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 475 INDIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 476 INDIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 477 INDIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 478 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 479 INDIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 480 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 481 INDIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 482 INDIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 483 INDIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 484 INDIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 485 INDIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 486 INDIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 487 INDIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 488 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 489 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 490 INDIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 491 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 492 SINGAPORE CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 493 SINGAPORE SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 494 SINGAPORE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 495 SINGAPORE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 496 SINGAPORE DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 497 SINGAPORE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 498 SINGAPORE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 499 SINGAPORE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 500 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 501 SINGAPORE SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 502 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 503 SINGAPORE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 504 SINGAPORE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 505 SINGAPORE DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 506 SINGAPORE DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 507 SINGAPORE DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 508 SINGAPORE PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 509 SINGAPORE AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 510 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 511 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 512 SINGAPORE RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 513 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 514 SOUTH KOREA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 515 SOUTH KOREA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 516 SOUTH KOREA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 517 SOUTH KOREA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 518 SOUTH KOREA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 519 SOUTH KOREA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 520 SOUTH KOREA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 521 SOUTH KOREA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 522 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 523 SOUTH KOREA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 524 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 525 SOUTH KOREA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 526 SOUTH KOREA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 527 SOUTH KOREA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 528 SOUTH KOREA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 529 SOUTH KOREA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 530 SOUTH KOREA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 531 SOUTH KOREA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 532 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 533 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 534 SOUTH KOREA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 535 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 536 MALAYSIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 537 MALAYSIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 538 MALAYSIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 539 MALAYSIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 540 MALAYSIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 541 MALAYSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 542 MALAYSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 543 MALAYSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 544 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 545 MALAYSIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 546 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 547 MALAYSIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 548 MALAYSIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 549 MALAYSIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 550 MALAYSIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 551 MALAYSIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 552 MALAYSIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 553 MALAYSIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 554 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 555 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 556 MALAYSIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 557 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 558 THAILAND CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 559 THAILAND SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 560 THAILAND SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 561 THAILAND SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 562 THAILAND DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 563 THAILAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 564 THAILAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 565 THAILAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 566 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 567 THAILAND SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 568 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 569 THAILAND PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 570 THAILAND PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 571 THAILAND DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 572 THAILAND DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 573 THAILAND DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 574 THAILAND PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 575 THAILAND AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 576 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 577 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 578 THAILAND RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 579 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 580 INDONESIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 581 INDONESIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 582 INDONESIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 583 INDONESIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 584 INDONESIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 585 INDONESIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 586 INDONESIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 587 INDONESIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 588 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 589 INDONESIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 590 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 591 INDONESIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 592 INDONESIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 593 INDONESIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 594 INDONESIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 595 INDONESIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 596 INDONESIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 597 INDONESIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 598 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 599 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 600 INDONESIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 601 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 602 PHILIPPINES CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 603 PHILIPPINES SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 604 PHILIPPINES SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 605 PHILIPPINES SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 606 PHILIPPINES DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 607 PHILIPPINES INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 608 PHILIPPINES INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 609 PHILIPPINES INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 610 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 611 PHILIPPINES SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 612 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 613 PHILIPPINES PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 614 PHILIPPINES PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 615 PHILIPPINES DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 616 PHILIPPINES DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 617 PHILIPPINES DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 618 PHILIPPINES PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 619 PHILIPPINES AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 620 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 621 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 622 PHILIPPINES RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 623 REST OF ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 624 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 625 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 626 SOUTH AMERICA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 627 SOUTH AMERICA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 628 SOUTH AMERICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 629 SOUTH AMERICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 630 SOUTH AMERICA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 631 SOUTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 632 SOUTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 633 SOUTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 634 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 635 SOUTH AMERICA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 636 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 637 SOUTH AMERICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 638 SOUTH AMERICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 639 SOUTH AMERICA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 640 SOUTH AMERICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 641 SOUTH AMERICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 642 SOUTH AMERICA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 643 SOUTH AMERICA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 644 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 645 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 646 SOUTH AMERICA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 647 BRAZIL NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 648 BRAZIL CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 649 BRAZIL SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 650 BRAZIL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 651 BRAZIL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 652 BRAZIL DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 653 BRAZIL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 654 BRAZIL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 655 BRAZIL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 656 BRAZIL NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 657 BRAZIL SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 658 BRAZIL NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 659 BRAZIL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 660 BRAZIL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 661 BRAZIL DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 662 BRAZIL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 663 BRAZIL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 664 BRAZIL PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 665 BRAZIL AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 666 BRAZIL NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 667 BRAZIL NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 668 BRAZIL RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 669 ARGENTINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 670 ARGENTINA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 671 ARGENTINA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 672 ARGENTINA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 673 ARGENTINA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 674 ARGENTINA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 675 ARGENTINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 676 ARGENTINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 677 ARGENTINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 678 ARGENTINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 679 ARGENTINA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 680 ARGENTINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 681 ARGENTINA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 682 ARGENTINA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 683 ARGENTINA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 684 ARGENTINA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 685 ARGENTINA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 686 ARGENTINA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 687 ARGENTINA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 688 ARGENTINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 689 ARGENTINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 690 ARGENTINA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 691 REST OF SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 692 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 693 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 694 MIDDLE EAST & AFRICA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 695 MIDDLE EAST & AFRICA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 696 MIDDLE EAST & AFRICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 697 MIDDLE EAST & AFRICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 698 MIDDLE EAST & AFRICA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 699 MIDDLE EAST & AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 700 MIDDLE EAST & AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 701 MIDDLE EAST & AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 702 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 703 MIDDLE EAST & AFRICA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 704 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 705 MIDDLE EAST & AFRICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 706 MIDDLE EAST & AFRICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 707 MIDDLE EAST & AFRICA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 708 MIDDLE EAST & AFRICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 709 MIDDLE EAST & AFRICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 710 MIDDLE EAST & AFRICA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 711 MIDDLE EAST & AFRICA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 712 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 713 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 714 MIDDLE EAST & AFRICA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 715 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 716 SOUTH AFRICA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 717 SOUTH AFRICA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 718 SOUTH AFRICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 719 SOUTH AFRICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 720 SOUTH AFRICA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 721 SOUTH AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 722 SOUTH AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 723 SOUTH AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 724 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 725 SOUTH AFRICA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 726 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 727 SOUTH AFRICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 728 SOUTH AFRICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 729 SOUTH AFRICA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 730 SOUTH AFRICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 731 SOUTH AFRICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 732 SOUTH AFRICA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 733 SOUTH AFRICA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 734 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 735 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 736 SOUTH AFRICA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 737 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 738 SAUDI ARABIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 739 SAUDI ARABIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 740 SAUDI ARABIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 741 SAUDI ARABIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 742 SAUDI ARABIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 743 SAUDI ARABIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 744 SAUDI ARABIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 745 SAUDI ARABIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 746 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 747 SAUDI ARABIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 748 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 749 SAUDI ARABIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 750 SAUDI ARABIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 751 SAUDI ARABIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 752 SAUDI ARABIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 753 SAUDI ARABIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 754 SAUDI ARABIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 755 SAUDI ARABIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 756 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 757 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 758 SAUDI ARABIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 759 U.A.E. NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 760 U.A.E. CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 761 U.A.E. SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 762 U.A.E. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 763 U.A.E. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 764 U.A.E. DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 765 U.A.E. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 766 U.A.E. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 767 U.A.E. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 768 U.A.E. NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 769 U.A.E. SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 770 U.A.E. NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 771 U.A.E. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 772 U.A.E. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 773 U.A.E. DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 774 U.A.E. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 775 U.A.E. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 776 U.A.E. PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 777 U.A.E. AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 778 U.A.E. NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 779 U.A.E. NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 780 U.A.E. RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 781 EGYPT NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 782 EGYPT CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 783 EGYPT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 784 EGYPT SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 785 EGYPT SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 786 EGYPT DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 787 EGYPT INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 788 EGYPT INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 789 EGYPT INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 790 EGYPT NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 791 EGYPT SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 792 EGYPT NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 793 EGYPT PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 794 EGYPT PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 795 EGYPT DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 796 EGYPT DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 797 EGYPT DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 798 EGYPT PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 799 EGYPT AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 800 EGYPT NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 801 EGYPT NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 802 EGYPT RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 803 ISRAEL NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 804 ISRAEL CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 805 ISRAEL SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 806 ISRAEL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 807 ISRAEL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)

TABLE 808 ISRAEL DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

TABLE 809 ISRAEL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 810 ISRAEL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 811 ISRAEL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 812 ISRAEL NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 813 ISRAEL SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 814 ISRAEL NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 815 ISRAEL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 816 ISRAEL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 817 ISRAEL DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 818 ISRAEL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 819 ISRAEL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 820 ISRAEL PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 821 ISRAEL AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 822 ISRAEL NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 823 ISRAEL NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 824 ISRAEL RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 825 REST OF MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)

Abbildungsverzeichnis

FIGURE 1 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: SEGMENTATION

FIGURE 2 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 8 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: SEGMENTATION

FIGURE 11 INCREASING ADOPTION OF NGS-BASED TESTS IN ONCOLOGY, PRENATAL SCREENING, AND INFECTIOUS DISEASE SURVEILLANCE IS DRIVING THE GROWTH OF THE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET FROM 2024 TO 2031

FIGURE 12 THE PRODUCT AND SERVICE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET IN 2024 AND 2031

FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2024 TO 2031

FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING REGION FOR NEXT GENERATION SEQUENCING (NGS) MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2024 TO 2031

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET

FIGURE 16 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY PRODUCT AND SERVICE 2023

FIGURE 17 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY PRODUCT AND SERVICES, 2024-2031 (USD MILLION)

FIGURE 18 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY PRODUCT AND SERVICE, CAGR (2024-2031)

FIGURE 19 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET BY PRODUCT AND SERVICE, LIFELINE CURVE

FIGURE 20 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY TECHNOLOGY 2023

FIGURE 21 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY TECHNOLOG, 2024-2031 (USD MILLION)

FIGURE 22 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY TECHNOLOG, CAGR (2024-2031)

FIGURE 23 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET BY TECHNOLOG, LIFELINE CURVE

FIGURE 24 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY APPLICATION, 2023

FIGURE 25 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY APPLICATION, 2024-2031 (USD MILLION)

FIGURE 26 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY APPLICATION, CAGR (2024-2031)

FIGURE 27 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY APPLICATION, LIFELINE CURVE

FIGURE 28 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY END USER, 2023

FIGURE 29 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY END USER, 2024-2031 (USD MILLION)

FIGURE 30 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY END USER, CAGR (2024-2031)

FIGURE 31 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY END USER, LIFELINE CURVE

FIGURE 32 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY DISTRIBUTION CHANNEL, 2023

FIGURE 33 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)

FIGURE 34 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY DISTRIBUTION CHANNEL, CAGR (2024-2031)

FIGURE 35 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 36 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: SNAPSHOT (2023)

FIGURE 37 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE 2023 (%)

FIGURE 38 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE 2023 (%)

FIGURE 39 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE 2023 (%)

FIGURE 40 AISA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE 2023 (%)

Detaillierte Informationen anzeigen

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

Welche Hauptsegmente werden im Globaler Markt-Bericht behandelt?

Der Markt ist basierend auf Globaler Markt für Next Generation Sequencing (NGS), nach Produkt und Service (Verbrauchsmaterialien, Dienstleistungen und Instrumente), Technologie (Sequenzierung durch Synthese (SBS), Sequenzierung durch Ligation (SBL) und andere), Anwendung (Pharma-Mikrobiologie, Arzneimittel- und Biomarkerforschung, Diagnostik, Präzisionsmedizin, Agrar- und Tierforschung, Screening auf Lebensmittelpathogene und andere), Endbenutzer (Pharma- und Biotechnologieunternehmen, akademische und Forschungsinstitute, Krankenhäuser und Kliniken, klinische Labore, Auftragsforschungsinstitute (CROS) und andere), Vertriebskanal (direkte Ausschreibung, Einzelhandelsverkauf und andere) – Branchentrends und Prognose bis 2031. segmentiert.

Wie groß ist der aktuelle Markt für Globaler Markt?

Die Größe des Globaler Markt wurde im Jahr 2023 auf 13.88 USD Billion USD geschätzt.

Wie hoch ist die erwartete Wachstumsrate von Globaler Markt?

Der Globaler Markt wird voraussichtlich mit einer CAGR von 15.1% im Prognosezeitraum 2024 bis 2031 wachsen.

Wer sind die Hauptakteure im Globaler Markt?

Die Hauptakteure auf dem Markt sind Agilent Technologies , ThermoFisher Scientific , QIAGEN, Illumina , BioRad Laboratories , Roche Sequencing, BGI, Oxford Nanopore Technologies plc, MACROGEN CO. , DNASTAR, Geneious, Partek orporated, PerkinElmer , Takara Bio , bioMérieux SA, Pacific Biosciences of California , GENEWIZ, 10x Genomics, New England Biolabs, Hamilton Company.

Globaler Markt für Next Generation Sequencing (NGS) – Branchentrends und Prognose bis 2031

Globaler Markt für Next Generation Sequencing (NGS) – Branchentrends und Prognose bis 2031

Global Next Generation Sequencing Ngs Market

CAGR : 15.10 %

Marktanalyse und -größe für Next Generation Sequencing (NGS)

Globale Marktdynamik für Next Generation Sequencing (NGS)

Globaler Marktumfang für Next Generation Sequencing (NGS)

Globaler Next Generation Sequencing (NGS)-Markt – Regionale Analyse/Einblicke

Wettbewerbsumfeld und globale Marktanteilsanalyse für Next Generation Sequencing (NGS)

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

Inhaltsverzeichnis

Tabellenverzeichnis

Abbildungsverzeichnis

Forschungsmethodik

Anpassung möglich

Häufig gestellte Fragen

Verwandte Seiten durchsuchen

Product manager, Fujifilms

Investor relations, GE Healthcare

Market Analyst, Medincell

Andrew - Senior Global Marketing Manager, Medtronic (US)

Amarildo - Manager, Global Strategic Alignment MasterCard

Tor Hammer Green Nexus LLc

Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,

Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions

Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC

Business Intelligence and Analytics, Ipsen Biopharm Limited

Competition Analyst, Basler Web

Marketing Director, Buhler Group

COO, A global leader providing Drug Delivery Services

Marketing Director, Philips Healthcare

Product manager, Fujifilms

Investor relations, GE Healthcare

Market Analyst, Medincell

Andrew - Senior Global Marketing Manager, Medtronic (US)

Amarildo - Manager, Global Strategic Alignment MasterCard

Tor Hammer Green Nexus LLc

Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,

Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions

Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC

Business Intelligence and Analytics, Ipsen Biopharm Limited

Competition Analyst, Basler Web

Marketing Director, Buhler Group

COO, A global leader providing Drug Delivery Services

Marketing Director, Philips Healthcare